Janelia Fluor® Fluorescent Dyes Recognized in 2018 CiteAb Awards

Dyes are Awarded "Highly Commended" in the Innovative Product Category

Tocris Bioscience, part of the Biotechnology division of Bio-Techne, is proud to announce that its Janelia Fluor® range of fluorescent dyes was awarded “Highly Commended” in the 2018 CiteAb awards Innovative Product of the Year category.

Tocris launched the first products in the Janelia Fluor® dyes range, JF646 and JF549, in February 2017.  These innovative small molecule fluorescent dyes are very bright and photostable, and importantly, they are cell-permeable, enabling live-cell intracellular imaging. The dyes were designed and developed at the Janelia Research Campus, part of the Howard Hughes Medical Institute (HHMI), in the lab of Professor Luke Lavis. Tocris acquired a license from HHMI to make the dyes commercially available and has recently added three new dyes to the Janelia Fluor® range.

Rob Felix, Head of Product Management at Tocris commented, “The Janelia Fluor® range truly represents a breakthrough in fluorescent dyes for microscopy, enabling life science researchers to acquire enhanced images, and it’s great that this has been recognized by the CiteAb awards.”

Janelia Fluor® dyes are suitable for use with both conventional imaging techniques, such as confocal microscopy, as well as super-resolution microscopy (SRM) techniques, including dSTORM.  In addition photoactivatable derivatives have been developed that are applicable in photo-activated localization microscopy (PALM).

For more information on Janelia Fluor® dyes see www.tocris.com/fluorescent-dyes

About Tocris Bioscience

Tocris Bioscience is part of the Biotechnology division of Bio-Techne. Our goal is to provide the global life science research community with the most innovative and high performing products to enable ground breaking discoveries. From its origins as a supplier of neuroscience research products, Tocris Bioscience has expanded to now offer innovative chemical tools for research in fields, such as cancer, epigenetics and stem cells.

Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. Bio-Techne has over 1,650 employees worldwide and generated $563 million in net sales in fiscal 2017. For more information on Bio-Techne and its brands, please visit bio-techne.com.